Symbols / PLRZ Stock $16.12 -1.35% Polyrizon Ltd.

Healthcare • Biotechnology • Israel • NCM
PLRZ (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Tomer Izraeli
Exch · Country NCM · Israel
Market Cap 30.17M
Enterprise Value 13.88M
Income -3.33M
Sales
FCF (ttm)
Book/sh 13.05
Cash/sh 7.57
Employees 2
Insider 10d
IPO Oct 29, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E
PEG
P/S
P/B 1.23
P/C
EV/EBITDA -2.35
EV/Sales
Quick Ratio 27.70
Current Ratio 29.03
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA -28.95%
ROE -25.38%
ROIC
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand
Shs Float 1.43M
Insider Own 0.96%
Instit Own 2.23%
Short Float 3.83%
Short Ratio 1.89
Short Interest 67.20K
52W High 628.50
vs 52W High -97.44%
52W Low 2.88
vs 52W Low 459.72%
Beta
Impl. Vol.
Rel Volume 0.79
Avg Volume 43.91K
Volume 34.83K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $16.34
Price $16.12
Change -1.35%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
5.79
+344.32%
1.30
+105.04%
0.64
-29.05%
0.90
Research And Development
2.13
+299.44%
0.53
+60.84%
0.33
-4.32%
0.35
Selling General And Administration
3.65
+375.52%
0.77
+153.47%
0.30
-44.71%
0.55
Selling And Marketing Expense
0.00
0.00
-100.00%
0.01
General And Administrative Expense
3.65
+375.52%
0.77
+153.47%
0.30
-43.15%
0.53
Salaries And Wages
1.13
+596.30%
0.16
-3.57%
0.17
-11.58%
0.19
Other Gand A
2.52
+316.50%
0.61
+348.89%
0.14
-60.64%
0.34
Total Expenses
5.79
+344.32%
1.30
+105.04%
0.64
-29.05%
0.90
Operating Income
-5.79
-344.32%
-1.30
-105.04%
-0.64
+29.05%
-0.90
Total Operating Income As Reported
-6.25
-379.95%
-1.30
-105.04%
-0.64
+29.05%
-0.90
EBITDA
-5.44
-359.71%
-1.18
-87.64%
-0.63
+29.10%
-0.89
Normalized EBITDA
-10.67
-1000.72%
-0.97
-8.15%
-0.90
+8.76%
-0.98
Reconciled Depreciation
0.34
+189.83%
0.12
+2850.00%
0.00
-20.00%
0.01
EBIT
-5.79
-344.32%
-1.30
-105.04%
-0.64
+29.05%
-0.90
Total Unusual Items
5.22
+2529.30%
-0.21
-181.13%
0.27
+188.04%
0.09
Total Unusual Items Excluding Goodwill
5.22
+2529.30%
-0.21
-181.13%
0.27
+188.04%
0.09
Special Income Charges
-0.46
Other Special Charges
0.46
Net Income
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Pretax Income
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Net Non Operating Interest Income Expense
-2.77
-9803.57%
-0.03
+87.83%
-0.23
-1058.33%
0.02
Net Interest Income
-2.77
-9803.57%
-0.03
+87.83%
-0.23
-1058.33%
0.02
Interest Income Non Operating
0.37
0.00
0.00
Interest Income
0.37
0.00
0.00
Other Income Expense
5.22
+2529.30%
-0.21
-181.13%
0.27
+188.04%
0.09
Gain On Sale Of Security
5.69
+2745.12%
-0.21
-181.13%
0.27
+188.04%
0.09
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Net Income From Continuing Operation Net Minority Interest
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Net Income From Continuing And Discontinued Operation
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Net Income Continuous Operations
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Normalized Income
-8.56
-543.46%
-1.33
-53.76%
-0.86
+0.69%
-0.87
Net Income Common Stockholders
-3.33
-107.79%
-1.60
-139.91%
-0.67
+18.71%
-0.82
Diluted EPS
-805.20
-236.52%
-239.27
+18.71%
-294.35
Basic EPS
-805.20
-236.52%
-239.27
+18.71%
-294.35
Basic Average Shares
0.00
-28.68%
0.00
+0.00%
0.00
Diluted Average Shares
0.00
-28.68%
0.00
+0.00%
0.00
Diluted NI Availto Com Stockholders
-3.33
-107.79%
-1.60
-139.91%
-0.67
+18.71%
-0.82
Preferred Stock Dividends
0.06
-13.04%
0.07
+56.82%
0.04
Total Other Finance Cost
3.14
+11125.00%
0.03
-87.83%
0.23
+1058.33%
-0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
21.44
+286.46%
5.55
+892.31%
0.56
+2.38%
0.55
Current Assets
12.86
+384.73%
2.65
+4812.96%
0.05
+5.88%
0.05
Cash Cash Equivalents And Short Term Investments
12.46
+388.02%
2.55
+6129.27%
0.04
+13.89%
0.04
Cash And Cash Equivalents
1.31
-48.86%
2.55
+63750.00%
0.00
-88.89%
0.04
Other Short Term Investments
11.16
0.00
-100.00%
0.04
0.00
Other Current Assets
0.40
+300.00%
0.10
+661.54%
0.01
-13.33%
0.01
Total Non Current Assets
8.58
+196.37%
2.89
+473.07%
0.51
+2.02%
0.49
Net PPE
0.01
+20.00%
0.01
-16.67%
0.01
-25.00%
0.02
Goodwill And Other Intangible Assets
2.55
-11.69%
2.88
0.00
Non Current Deferred Assets
0.00
-100.00%
0.49
+2.92%
0.48
Non Current Prepaid Assets
6.02
0.00
Total Liabilities Net Minority Interest
0.44
+69.73%
0.26
-65.20%
0.75
-48.13%
1.45
Current Liabilities
0.44
+69.73%
0.26
-48.01%
0.50
-58.10%
1.20
Payables And Accrued Expenses
0.29
+36.11%
0.22
+36.71%
0.16
+12.06%
0.14
Current Accrued Expenses
0.29
+36.11%
0.22
+36.71%
0.16
+12.06%
0.14
Pensionand Other Post Retirement Benefit Plans Current
0.15
+231.11%
0.04
+15.38%
0.04
+5.41%
0.04
Current Debt And Capital Lease Obligation
0.20
-67.85%
0.62
Current Debt
0.20
-67.85%
0.62
Other Current Borrowings
0.20
-67.85%
0.62
Other Current Liabilities
0.10
-73.62%
0.40
Total Non Current Liabilities Net Minority Interest
0.00
0.00
-100.00%
0.25
+0.00%
0.25
Preferred Securities Outside Stock Equity
0.00
-100.00%
0.25
+0.00%
0.25
Stockholders Equity
20.99
+297.16%
5.29
+2867.54%
-0.19
+78.78%
-0.90
Common Stock Equity
20.99
+297.16%
5.29
+2867.54%
-0.19
+78.78%
-0.90
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Share Issued
1.61
+57420.24%
0.00
+0.00%
0.00
+0.00%
0.00
Ordinary Shares Number
1.61
+57420.24%
0.00
+0.00%
0.00
+0.00%
0.00
Additional Paid In Capital
29.39
+183.95%
10.35
+193.59%
3.53
+74.47%
2.02
Retained Earnings
-8.40
-65.83%
-5.07
-43.88%
-3.52
-20.54%
-2.92
Total Equity Gross Minority Interest
20.99
+297.16%
5.29
+2867.54%
-0.19
+78.78%
-0.90
Total Capitalization
20.99
+297.16%
5.29
+2867.54%
-0.19
+78.78%
-0.90
Working Capital
12.42
+419.11%
2.39
+633.93%
-0.45
+60.94%
-1.15
Invested Capital
20.99
+297.16%
5.29
+58633.33%
0.01
+103.24%
-0.28
Total Debt
0.20
-67.85%
0.62
Net Debt
0.20
-66.55%
0.59
Net Tangible Assets
18.45
+667.99%
2.40
+1357.59%
-0.19
+78.78%
-0.90
Tangible Book Value
18.45
+667.99%
2.40
+1357.59%
-0.19
+78.78%
-0.90
Other Equity Interest
-0.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.53
-294.77%
-1.15
-113.59%
-0.54
+52.56%
-1.13
Cash Flow From Continuing Operating Activities
-4.53
-294.77%
-1.15
-113.59%
-0.54
+52.56%
-1.13
Net Income From Continuing Operations
-3.33
-115.86%
-1.54
-157.50%
-0.60
+22.98%
-0.78
Depreciation Amortization Depletion
0.34
+189.83%
0.12
+2850.00%
0.00
-20.00%
0.01
Depreciation
0.12
+2850.00%
0.00
-20.00%
0.01
Depreciation And Amortization
0.34
+189.83%
0.12
+2850.00%
0.00
-20.00%
0.01
Other Non Cash Items
2.46
+7825.81%
0.03
-86.40%
0.23
+976.92%
-0.03
Stock Based Compensation
1.31
+2468.63%
0.05
-49.00%
0.10
-23.08%
0.13
Operating Gains Losses
-5.14
-2537.91%
0.21
+172.01%
-0.29
-148.31%
-0.12
Gain Loss On Investment Securities
-5.14
-2537.91%
0.21
+172.01%
-0.29
-148.31%
-0.12
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
0.01
-52.94%
0.02
0.00
Change In Working Capital
-0.16
-652.38%
-0.02
-400.00%
0.01
+102.03%
-0.34
Change In Payables And Accrued Expense
0.04
-39.66%
0.06
+241.18%
0.02
+213.33%
-0.01
Change In Accrued Expense
0.04
-39.66%
0.06
+241.18%
0.02
+213.33%
-0.01
Change In Other Working Capital
0.10
+1633.33%
0.01
+150.00%
-0.01
+96.42%
-0.34
Change In Other Current Assets
-0.30
-249.41%
-0.09
-4350.00%
0.00
-66.67%
0.01
Investing Cash Flow
-16.53
-57113.79%
0.03
0.00
+100.00%
-0.00
Cash Flow From Continuing Investing Activities
-16.53
-57113.79%
0.03
0.00
+100.00%
-0.00
Net PPE Purchase And Sale
-0.01
0.00
0.00
+100.00%
-0.00
Purchase Of PPE
-0.01
0.00
0.00
+100.00%
-0.00
Capital Expenditure
-0.01
-0.00
Net Investment Purchase And Sale
-16.53
-57089.66%
0.03
0.00
0.00
Purchase Of Investment
-16.53
0.00
0.00
Sale Of Investment
0.00
-100.00%
0.03
0.00
0.00
Financing Cash Flow
19.81
+440.19%
3.67
+626.34%
0.51
-22.07%
0.65
Cash Flow From Continuing Financing Activities
19.81
+440.19%
3.67
+626.34%
0.51
-22.07%
0.65
Net Issuance Payments Of Debt
0.00
+100.00%
-0.01
-102.41%
0.25
-61.57%
0.65
Issuance Of Debt
0.00
-100.00%
0.31
+24.50%
0.25
-61.57%
0.65
Repayment Of Debt
0.00
+100.00%
-0.32
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
0.31
0.00
0.00
Long Term Debt Payments
0.00
+100.00%
-0.32
0.00
0.00
Net Long Term Debt Issuance
0.00
+100.00%
-0.01
0.00
0.00
Short Term Debt Issuance
0.00
0.00
-100.00%
0.25
-61.57%
0.65
Net Short Term Debt Issuance
0.00
0.00
-100.00%
0.25
-61.57%
0.65
Net Common Stock Issuance
19.81
+439.30%
3.67
+1335.16%
0.26
0.00
Changes In Cash
-1.25
-148.94%
2.55
+8068.75%
-0.03
+93.43%
-0.49
Beginning Cash Position
2.55
+63750.00%
0.00
-88.89%
0.04
-93.12%
0.52
End Cash Position
1.31
-48.86%
2.55
+63750.00%
0.00
-88.89%
0.04
Free Cash Flow
-4.54
-295.38%
-1.15
-113.59%
-0.54
+52.69%
-1.14
Common Stock Issuance
19.81
+439.30%
3.67
+1335.16%
0.26
0.00
Issuance Of Capital Stock
19.81
+439.30%
3.67
+1335.16%
0.26
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category